Tema Etfs LLC Cogent Biosciences, Inc. Transaction History
Tema Etfs LLC
- $335 Billion
- Q1 2025
A detailed history of Tema Etfs LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 71,563 shares of COGT stock, worth $389,302. This represents 0.13% of its overall portfolio holdings.
Number of Shares
71,563
Previous 51,926
37.82%
Holding current value
$389,302
Previous $405 Million
5.84%
% of portfolio
0.13%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding COGT
# of Institutions
196Shares Held
116MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$49.5 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$48.8 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$48.4 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$39.6 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$37.9 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $358M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...